January 30, 2019
Post-Authorization Safety Study of GSK Biologicals’ Pandemic Influenza Vaccine (H1N1) in the United Kingdom
Read More
December 10, 2018
A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
Read More
December 10, 2018
Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP)
Read More
X